Medical News |
- Platelet size may predict response to antiplatelet therapy
- Novel CHADS-based score improves LAAT prediction in AF
- BMI not associated with biochemical failure after prostate cancer treatment
- BMI not associated with biochemical failure after prostate cancer treatment
- Several factors influence breast cancer brain metastasis survival
- Inflammation compromises HDL protective ability
- Key step in early atherogenesis revealed
- Rural-to-urban migration increases risk for diabetes and overweight in India
- High pulse pressure predicts new-onset diabetes in hypertensive patients
- Magnetic nanoparticles could improve stent drug delivery
- Personalized medicine a step closer?
- Several factors influence breast cancer brain metastasis survival
| Platelet size may predict response to antiplatelet therapy Posted: 29 Apr 2010 05:00 PM PDT PPre-procedural platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and correlates positively with future residual platelet reactivity under aspirin and clopidogrel therapy, Polish researchers report. |
| Novel CHADS-based score improves LAAT prediction in AF Posted: 29 Apr 2010 05:00 PM PDT A modified CHADS2 score combined with echocardiographic measures is a good predictor of left atrial appendage thrombus in patients with atrial fibrillation, report US researchers. |
| BMI not associated with biochemical failure after prostate cancer treatment Posted: 29 Apr 2010 05:00 PM PDT Researchers have found that body mass index does not indicate whether a prostate cancer patient is likely to experience biochemical failure after radiotherapy or surgery, once potential confounding factors are taken into account. |
| BMI not associated with biochemical failure after prostate cancer treatment Posted: 29 Apr 2010 05:00 PM PDT Researchers have found that body mass index does not indicate whether a prostate cancer patient is likely to experience biochemical failure after radiotherapy or surgery, once potential confounding factors are taken into account. |
| Several factors influence breast cancer brain metastasis survival Posted: 29 Apr 2010 05:00 PM PDT Prognostic class, the occurrence of visceral metastasis and the use of systemic treatment after whole brain radiotherapy are the most important factors influencing survival in patients with breast cancer brain metastasis, Polish research shows. |
| Inflammation compromises HDL protective ability Posted: 29 Apr 2010 05:00 PM PDT High levels of high-density lipoprotein cholesterol are unable to protect men with elevated C-reactive protein levels against cardiovascular events, shows research. |
| Key step in early atherogenesis revealed Posted: 29 Apr 2010 05:00 PM PDT The deposition of tiny crystals of cholesterol in the arterial wall is one of the earliest events in atherosclerosis, and directly initiates inflammation, indicates a study in Nature. |
| Rural-to-urban migration increases risk for diabetes and overweight in India Posted: 29 Apr 2010 05:00 PM PDT Migration from a rural to an urban environment in India is associated with increased prevalence of overweight and diabetes, report researchers. |
| High pulse pressure predicts new-onset diabetes in hypertensive patients Posted: 29 Apr 2010 05:00 PM PDT High pulse pressure increases the risk for new-onset diabetes in Japanese patients with hypertension, show results from the CASE-J trial. |
| Magnetic nanoparticles could improve stent drug delivery Posted: 29 Apr 2010 05:00 PM PDT Stent-targeted magnetic nanoparticles loaded with paclitaxel resulted in significant inhibition of in-stent restenosis at a relatively low dose of the drug, preliminary research shows. |
| Personalized medicine a step closer? Posted: 29 Apr 2010 05:00 PM PDT Whole-genome sequencing can provide useful and clinically relevant information for individual patients, suggests a study of a patient with a family history of vascular disease and early sudden death. |
| Several factors influence breast cancer brain metastasis survival Posted: 29 Apr 2010 05:00 PM PDT Prognostic class, the occurrence of visceral metastasis and the use of systemic treatment after whole brain radiotherapy are the most important factors influencing survival in patients with breast cancer brain metastasis, Polish research shows. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment